New hope for microscopic colitis: can a drug replace steroids?

NCT ID NCT07156175

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Oct 01, 2025 · Last updated May 12, 2026 · Updated 31 times

Summary

This study tests an experimental drug called SAR444336 in 54 adults with microscopic colitis who are currently in remission using budesonide (a steroid). The goal is to see if the drug can keep them symptom-free without needing steroids for 24 weeks. Participants will receive either the drug or a placebo, and researchers will monitor safety and effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, S.C. Gastroenterologia U., Investigational Site Number : 380002
RECRUITING

Turin, Torino, 10126, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Azienda Ospedale Università Padova, Investigational Site Number : 380001
RECRUITING

Padua, Padova, 35128, Italy

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Investigational Site Number : 380004
RECRUITING

Milan, Milano, 20122, Italy

Contact Email: •••••@•••••

Contact
Fondazione Policlinico Gemelli IRCCS Roma, Investigational Site Number : 380003
RECRUITING

Rome, Roma, 00168, Italy

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Investigational Site Number : 0560001
RECRUITING

Leuven, 3000, Belgium
Investigational Site Number : 0560002
RECRUITING

Ghent, 9000, Belgium
Investigational Site Number : 2080002
RECRUITING

Hvidovre, 2650, Denmark
Investigational Site Number : 2080003
RECRUITING

Aarhus, 8200, Denmark
Investigational Site Number : 2500001
RECRUITING

Créteil, 94010, France
Investigational Site Number : 2500002
RECRUITING

Montfermeil, 93370, France
Investigational Site Number : 2500003
RECRUITING

Pessac, 33604, France
Investigational Site Number : 2760001
RECRUITING

Frankfurt, 60389, Germany
Investigational Site Number : 2760002
RECRUITING

Potsdam, 14467, Germany
Investigational Site Number : 2760003
RECRUITING

Tübingen, 72076, Germany
Investigational Site Number : 2760004
RECRUITING

Ulm, 89081, Germany
Investigational Site Number : 2760005
RECRUITING

Ludwigshafen, 67067, Germany
Investigational Site Number : 3480002
RECRUITING

Budapest, 1085, Hungary
Investigational Site Number : 3480003
RECRUITING

Székesfehérvár, 8000, Hungary
Investigational Site Number : 6160002
RECRUITING

Warsaw, Masovian Voivodeship, 02-507, Poland
Investigational Site Number : 6160003
RECRUITING

Warsaw, Masovian Voivodeship, 00-728, Poland
Investigational Site Number : 6160004
RECRUITING

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-229, Poland
Investigational Site Number : 7520001
RECRUITING

Linköping, 581 85, Sweden
Investigational Site Number : 7520002
RECRUITING

Stockholm, 113 61, Sweden
Investigational Site Number : 7520003
RECRUITING

Stockholm, 116 91, Sweden
Investigational Site Number : 8260001
RECRUITING

Oxford, Oxfordshire, OX3 9DU, United Kingdom
Investigational Site Number : 8260002
RECRUITING

Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom

Conditions

Explore the condition pages connected to this study.

MICROSCOPIC COLITIS